ACR Alpine Capital Research Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$76.5M |
| 2 |
FLOW
SPX FLOW, Inc.
FLOW
|
+$42.8M |
| 3 |
Walmart Inc
WMT
|
+$38.6M |
| 4 |
SPX Corp
SPXC
|
+$19.5M |
| 5 |
Intel
INTC
|
+$18.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sysco
SYY
|
+$73.8M |
| 2 |
Merck
MRK
|
+$1.3M |
| 3 |
Humana
HUM
|
+$80K |
| 4 |
Vanguard Total Stock Market ETF
VTI
|
+$51.9K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.95% |
| 2 | Technology | 22.23% |
| 3 | Industrials | 15.38% |
| 4 | Financials | 14.48% |
| 5 | Consumer Staples | 9.59% |
Similar funds
ACR Alpine Capital Research's Q3 2015 Portfolio in Review
As of Q3 2015, ACR Alpine Capital Research held 25 positions worth $913M, up 14% from $801M the previous quarter. Its ten largest holdings account for 90% of the portfolio.
ACR Alpine Capital Research deployed $168M of net new capital in Q3 2015, opening 3 new positions and adding to 14 existing holdings. Its largest new stake was PRECISION CASTPARTS CORP: 356,402 shares worth $81.9M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 29% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Sysco, an estimated $73.8M trimmed.
- ACR Alpine Capital Research's largest Q3 2015 buy was PRECISION CASTPARTS CORP: 356,402 shares worth $81.9M.
- ACR Alpine Capital Research added most to Walmart Inc in Q3 2015, an estimated $38.6M increase.
- ACR Alpine Capital Research's biggest Q3 2015 reduction was Sysco, cutting an estimated $73.8M.
- ACR Alpine Capital Research fully exited Humana in Q3 2015, selling an estimated $80K.
- ACR Alpine Capital Research's ten largest holdings make up 90% of its $913M portfolio in Q3 2015.
- ACR Alpine Capital Research opened 3 new positions and closed 1 in Q3 2015.
- ACR Alpine Capital Research's portfolio value rose 14% quarter-over-quarter to $913M.
Based on ACR Alpine Capital Research's 13F filing for Q3 2015, filed 13 Nov 2015.